Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0646
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors ; day:10 ; month:12 ; year:2019 ; pages:1-7
Investigational new drugs ; (10.12.2019), 1-7
- Urheber
-
Ando, Yosuke
Hayashi, Takahiro
Sugimoto, Reiko
Nishibe, Seira
Ito, Kaori
Kawada, Kenji
Ikeda, Yoshiaki
Yamada, Shigeki
Imaizumi, Kazuyoshi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10637-019-00881-6
- URN
-
urn:nbn:de:101:1-2020040506235136312234
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ando, Yosuke
- Hayashi, Takahiro
- Sugimoto, Reiko
- Nishibe, Seira
- Ito, Kaori
- Kawada, Kenji
- Ikeda, Yoshiaki
- Yamada, Shigeki
- Imaizumi, Kazuyoshi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis
Cancer-associated thrombosis in Asia
Safety of Apixaban for Cancer-Associated Thrombosis
Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
Therapeutic Shifts in the Management of Cancer-Associated Thrombosis
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
Proper application of anticoagulation therapy on cancer-associated venous thrombosis
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade
Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis